Share this article Share The numbers are rising in the US, with more than 2.6 million Americans now receiving treatment for primary disseminated haemophilia, a disease that is the primary cause of the infection.
In addition, 1.9 million Americans have received treatment for secondary dissemination of the disease, which can also lead to other illnesses, including meningitis.
But as the disease’s number of cases continues to rise, there are fears the epidemic will become too large to contain.
The US Centers for Disease Control and Prevention says there are nearly 17 million new cases of primary disseminating haemochromatosis each year, which is more than double the number in 2016.
The disease has been around for centuries and is associated with an increased risk of death from infectious complications and other life-threatening infections.
The number of primary cases has been steadily increasing in the United States, with the number of new infections per capita now exceeding the number for Europe and Japan, according to the CDC.
But while the US is catching up with Europe and other developed nations in terms of the number and number of infections, there is a gap of about 30 million infections, according the CDC, with about 5 million of those occurring in the states of California and Nevada.
While there has been a spike in primary cases, it has not been without its challenges.
There are now more than 14,000 deaths annually due to the disease in the U.S. The CDC estimates that as many as 30,000 people die annually due the disease.
A recent study by the Center for Disease Dynamics and Prevention estimated that as much as $1.4 trillion is spent annually on the disease as of 2018.
So far, the CDC estimates more than 9,000 new cases a day will occur this year in the country, according CNN.
However, according a study by The New England Journal of Medicine, only around 15 percent of those cases are associated with the disease at this point.
That means more than 20 percent of people who contract the disease are not going to have any complications.
That’s one reason why the United Nations has called for a $1 billion global effort to address the disease and help slow the spread.